Merri Maven

Stripped of the closing supplement-brand mention ("The Pause Life"), the general fiber-and-insulin claim is well established: the Women's Health Trial found a higher fiber-to-energy ratio associated with lower insulin in postmenopausal women, independent of weight. The more specific point, that this matters especially in perimenopause, is also backed by recent, converging data: the ZOE PREDICT study (over 1,000 women, continuous glucose monitors) found postprandial glucose and insulin responses rise notably after menopause (+42% glucose AUC), and a 2025 SWAN cohort study links higher fasting insulin in early perimenopause to earlier and longer-lasting hot flashes. The natural decline in insulin sensitivity around menopause is therefore a real, documented phenomenon, which makes the post's targeted audience relevant rather than arbitrary. The practical advice stays fairly general ("add fiber") without a precise amount, and the brand mention at the end should be judged separately from the underlying scientific claim.